Hepatitis B questions you should ask your doctor

In this episode, Bright and Anousha speak with Bruno D’Amato, a hepatitis B advocate whose diagnosis came decades after an unexpected hospital exposure. Symptom-free for years, Bruno’s routine tests later revealed liver fibrosis, prompting life-changing treatment. He shares his journey from silent infection to healing and the importance of regular monitoring, self-care, and hope. Learn more about Bruno's story here: https://youtu.be/CYlyc1l3blQSupport the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In this episode, Bright and Anousha welcome Dr. Catherine Freeland and Pharmacist Prince Okinedo, advisory board members of the African Hepatitis B Advocacy Coalition (ABAC). They discuss the Coalition’s launch and its mission to advance hepatitis B advocacy across Africa. Learn more about ABAC here: https://abachepb.org/Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In this episode, Anousha is joined by Dr. Su Wang, Medical Director of the Chinese Medical Program at Cooperman Barnabas Medical Center and Medical Advisor to the Hepatitis B Foundation, along with Dr. Thomas Tu, Molecular Biologist at the Westmead Institute for Medical Research in Australia. Together, they discuss expanding hepatitis B treatment guidelines by broadening eligibility criteria, improving access, reducing loss to follow-up, and the importance of including public health and patient perspectives in guideline development. Read more about their new paper here: https://pubmed.ncbi.nlm.nih.gov/40714036/Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In this episode, we speak with Dr. Claudia Hawkins, Director of the Center for Global Communicable and Emerging Infectious Diseases at Northwestern University. Dr. Hawkins leads the H2NET Initiative, a groundbreaking effort focused on addressing critical research gaps in Hepatitis B (HBV) and HIV/HBV co-infection across Sub-Saharan Africa. She shares insights into the challenges of HBV research in resource-limited settings, the importance of building local research capacity, and how H2NET is fostering collaboration to improve health outcomes in the region. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In this episode, Bright and Anousha invited Dr. David Higgins, a pediatrician and leading expert in vaccine delivery and communication from University of Colorado Anschutz Medical Campus. He sheds light on common myths and misconceptions about the hepatitis B birth dose and offers practical strategies for healthcare providers and advocates to address concerns with parents using empathy and evidence-based science.Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In this episode, Bright and Anousha are joined by Dr. Bethany Holt, Associate Director of Health Systems at Harvard Medical School’s Program in Global Primary Health Care, and Imee Lacson, a patient advocate with the Yellow Warriors Society. Together, they explore how hepatitis B can be integrated into primary care and discuss strategies for strengthening health systems to address hepatitis B in the Philippines and Vietnam.Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In this episode, Bright and Anousha are joined by researchers Philippa Mathews of the Crick Institute and Louise Downs of Oxford University to discuss their latest findings on the devastating financial impact of hepatitis B on patients and their families. They unpack key insights from their recent paper, shedding light on the hidden costs of care. The episode also features a powerful segment from patient advocate Joy Koy, who shares a firsthand perspective on the economic burden of living with hepatitis B.Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In this episode, Bright and Anousha spoke with Dr. Nancy Reau from Rush University to share insights and updates on current treatments in development for hepatitis B.Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Hear from Lou Kassa, CEO of the Hepatitis B Foundation, Blumberg Institute, and Pennsylvania Biotechnology Center, and Chari Cohen, President of the Hepatitis B Foundation in an interview for our podcast as they discuss what these changes mean for our organizations and others like us. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In this episode, we welcomed Heidi Emery and Kathryn Jack to discuss their qualitative review on the barriers and facilitators of hepatitis B programs and services for prison inmates. Read more about their research here: https://pubmed.ncbi.nlm.nih.gov/39731473/Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook